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Abstract: Backgroud: Lippia alba (Verbenaceae) is a plant widely used in folk medicine to treat various
diseases. The present work deals with the chemical composition of the crude essential oil extracted
from leaves of L. alba and evaluation of its antimicrobial and cytotoxic activities. Methods: Leaves of
L. alba were extracted by hydrodistillation and analyzed by gas chromatography/mass spectrometry
(GC/MS) as well as by nuclear magnetic resonance (NMR) spectroscopy. Cytotoxic and antimicrobial
activities of crude essential oil were evaluated in vitro using MTT and broth microdilution assays,
respectively. Results: Chemical analysis afforded the identification of 39 substances corresponding
to 99.45% of the total oil composition. Concerning the main compounds, monoterpenes nerol/geraniol
and citral correspond to approximately 50% of crude oil. The cytotoxic activity of obtained
essential oil against several tumor cell lines showed IC50 values ranging from 45 to 64 µg/mL
for B16F10Nex2 (murine melanoma) and A549 (human lung adenocarcinoma). In the antimicrobial
assay, was observed that all tested yeast strains, except C. albicans, were sensitive to crude essential
oil. MIC values were two to four-folds lower than those determined to bacterial strains. Conclusion:
Analysis of chemical composition of essential oils from leaves of L. alba suggested a new chemotype
nerol/geraniol and citral. Based in biological evidences, a possible application for studied oil as an
antifungal in medicine, as well as in agriculture, is described.
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1. Introduction
The Verbenaceae family, with tropical and subtropical distribution, is composed of approximately
90 genera, including Lippia [1], with more than 200 species of herbaceous plants, small shrubs,
and trees [2,3]. Most of these species have traditionally been used in the treatment of gastrointestinal
and respiratory diseases [4]. Several pharmacological aspects have been ascribed to the genus
Lippia, including antimicrobial, antifungal, antimalarial, larvicidal, antispasmodic, analgesic,
anti-inflammatory, and antipyretic activities. Lippia alba (Mill.) N.E. Brown is native to the Americas
widely distributed across the Southern United States and Northern Argentina [5]. In Brazil, this plant
is popularly known as lemon balm [6,7] and have been used in folk medicine for the treatment of
various diseases, such as gastric diseases, diarrhea, fever, asthma, cough, and soothing, antispasmodic,
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and emenagoga [2,8–13]. As other species from the same genus, phytochemicals from L. alba
exhibited antibacterial, antifungal, antiviral, antiprotozoal, analgesic, anti-inflammatory, cytotoxic,
antioxidant, and acaricidal activities [5]. Essential oils obtained from the leaves of L. alba were
previously studied and three different chemotypes were reported: myrcene/citral, limonene/citral
and limonene/carvone [14]. Zoghbi et al. [15] classified three other chemotypes: eucalyptol/limonene,
limonene/carvone, and citral/germacrene-D. In addition to these volatile compounds, other
monoterpenes and phenylpropanoids have been described as main metabolites in the essential oils
from L. alba: linalool, β-caryophyllene, tagetone, myrcene, γ-terpinene, camphor, estragole, eucalyptol,
camphor, limonene, and piperitone [12–18]. This variability has been explained due to factors such as
seasons, flowering time, plant age, amount of precipitation, geographic and climatic factors [8,12,19], as
well as the part of the studied plant, extraction method, soil characteristics, and the genetic variability
of these plants [12,20–23]. These differences may lead to a different oil composition and, therefore,
to different pharmacological effects [9,12]. As part of our continuous study with volatile oils from
Brazilian species [24–26], the present work deals with the chemical composition of the essential oil
from leaves of the Brazilian species of L. alba, as well as the cytotoxic and antimicrobial evaluation of
crude essential oil.
2. Materials and Methods
2.1. General Experimental Procedures
1H and 13C NMR spectra of crude oil were registered, respectively, at 300 and 75 MHz into
a Ultrashield 300 Advance III spectrometer (Bruker, Fremont, CA, USA) using CDCl3 (Aldrich,
St. Louis, MO, USA) as solvent and tetramethylsilane (TMS) as internal standard. Gas chromatograms
were obtained on a GC-2010 gas chromatograph (Shimadzu, Kyoto, Japan) equipped with an
FID-detector and AOC-20i automatic injector (Shimadzu, Kyoto, Japan) using a RtX-5 (5% phenyl,
95% polydimethylsiloxane-30 m × 0.32 mm × 0.25 µm film thickness, Restek (Bellefonte, PA,
USA)) capillary column. These analyses were performed by injecting 1.0 µL of a 1.0 mg/mL
solution of volatile oil in CH2Cl2 in a split mode (1:10) employing helium as the carrier gas
(1 mL/min) under the following conditions: injector and detector temperatures of 220 ◦C and 250 ◦C,
respectively; oven programmed temperature from 40 to 240 ◦C at 3 ◦C/min, holding 5 min at 240 ◦C.
The percentage compositions of the oil samples were computed by internal normalization from the
flame ionization detector gas chromatography (GC-FID) peak areas without using correction for
response factors. Gas chromatography coupled to low resolution electronic impact mass spectrometry
(GC-LREIMS) analysis was conducted in a GC-17A chromatograph interfaced with a MS-QP-5050A
mass spectrometer (Shimadzu, Kyoto, Japan). The LREIMS operating conditions were an ionization
voltage of 70 eV and an ion source temperature of 230 ◦C with the same conditions described above.
The identification of the individual compounds was performed by comparison of retention indexes
(determined relatively to the retention times of a series of n-alkanes) and comparison of recorded mass
spectra with those available in the system [27].
2.2. Plant Material
Leaves of L. alba were collected at Instituto Plantarum de Estudos da Flora in Nova Odessa
city (coordinates 22◦46’46” S e 47◦18’49” O), São Paulo State, Brazil in 2014. Botanical identification
was performed by Dr. Harri Lorenzi. The voucher of the studied species has been deposited in the
Herbarium Plantarum (HPL) at number Lorenzi 1.713.
2.3. Essential Oil Extraction and Analysis
Fresh leaves (150 g) of L. alba were submitted to a steam distillation in a Clevenger-type apparatus
over 5 h to afford 931 mg of the crude essential oil. The obtained oil was immediately analyzed by
GC-FID and GC-LREIMS.
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2.4. Cell Lines
The murine melanoma cell line B16F10 was originally obtained from the Ludwig Institute
for Cancer Research (São Paulo, Brazil). The melanotic B16F10Nex2 subline, characterized at the
Experimental Oncology Unit (UNIFESP-Federal University of São Paulo), is characterized by low
immunogenicity and moderate virulence. Human breast cancer cell line (MCF-7), human lung
adenocarcinoma (A549), and human umbilical vein endothelial (HUVEC) were obtained from the
Ludwig Institute for Cancer Research.
2.5. In Vitro Cytotoxic Activity
The essential oil extracted from leaves of L. alba was dissolved in dimethyl sulfoxide (DMSO)
to the final concentration of 10 mg/mL, diluted in RPMI medium containing 10% fetal calf serum
ranging from 100 to 0 µg/mL and incubated with 1 × 104 cells in a 96-well plate. After 18 h of
incubation, cell viability was measured using the Cell Proliferation Kit I (MTT) (Sigma, St. Louis, MI,
USA), an MTT-based colorimetric assay [27,28]. Readings were made with a plate reader at 570 nm.
All experiments were performed in triplicate.
2.6. Media, Antibiotics, and Growth Conditions
Yeast were cultivated on agar plates containing YPD (1% yeast extract, 2% peptone, 2% dextrose,
and 2% agar) or RPMI1640 (Sigma). Gram-negative bacteria were grown in LB (0.5% yeast extract,
1% tryptone, 1% NaCl, and 2% agar) and Gram-positive bacteria were tested in BHI (Himedia, Mumbai,
India). Fluconazole (Sigma) was used as the positive control for yeast and chloramphenicol (Sigma)
was the positive control for bacteria. Crude essential oil from L. alba was diluted in DMSO or saline
(0.9%) plus Tween 80 (0.5%) and spotted on 5 mm sterile filter paper [25].
2.7. Microorganisms Strains
The bacteria and yeast species used in this work are described in the Table 1.
Table 1. Target strains used for antimicrobial activity assays.
Species Designation
Yeast
Candida dubliniensis ATCC 7978
Candida tropicalis ATCC 13803
Candida glabrata ATCC 90030
Candida parapsilosis Clinical isolate 68
Candida krusei Clinical isolate 9602
Candida albicans CBMAI * 560
Cryptococcus grubii (A) ATCC 208821
Cryptococcus gattii (B) ATCC MYA-4563
Cryptococcus gattii (C) ATCC MYA-4560
Cryptococcus neoformans (D) ATCC MYA-4567
Saccharomyces cerevisiae ATCC 201389
Bacteria
Escherichia coli -
Serratia marcescens CBMAI * 469
Pseudomonas aeruginosa CBMAI * 602
Staphylococcus epidermidis CBMAI * 604
Enterococcus faecalis -
* CBMAI: Coleção Brasileira de Microrganismos do Ambiente e Indústria.
2.8. Disk Diffusion Assay
Antimicrobial activity of essential oil from leaves of L. alba was evaluated using the disk diffusion
method according to the Clinical and Laboratory Standards Institute (CLSI, OPAS M2-A8) with
modifications. Thin agar plates were prepared with 10 mL of YPD (yeast), LB (Gram-negative) and
BHI (Gram-positive) media. Three milliliters of liquid cultures were grown at 30 ◦C with aeration
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(150 rpm) overnight on YPD (yeast), LB (Gram-negative), or BHI (Gram-positive). A top agar was
prepared by mixing 100 µL of each culture with 10 mL of soft agar medium for confluent plates (YPD,
LB or BHI plus 1% agar) and poured on top of the thin agar (2% agar medium). Sterilized 5 mm filter
paper disks were then impregnated with 20 µL of crude essential oil diluted in DMSO. The disks were
placed on top of agar plates and incubated at 30 ◦C for 24 or 48 h depending on the microorganism.
Fluconazole (1 mg) and chloramphenicol (200 µg) were used as positive controls for yeast and bacteria,
respectively. Negative control was prepared by impregnating the paper disks with the same amount
of DMSO used to dilute the essential oil. All tests were performed in triplicate. Tested strains were
selected since they represent clinical important microbes and were previously tested in other studies
conducted by our research group [25].
2.9. Minimum Inhibitory Concentration
Microdilution tests were conducted according to the Clinical and Laboratory Standards Institute
(CLSI), OPAS1 M27-A2 for yeasts and OPAS M7-A6 for bacteria according to literature [25] with
slight modifications. Briefly, minimum inhibitory concentration (MIC) values were determined using
microtiter plates (96 wells) with a total volume of 100 µL. Microorganisms were cultured in test tubes
filled with 3 mL medium RPMI 1640 (Sigma, St. Louis, MI, USA) for yeast and BHI (Sigma, St. Louis,
MI, USA) for bacteria, overnight at 30 ◦C in a rotary shaker (150 rpm). The cultures were diluted and
adjusted to 1–2 × 102 CFU/mL, which was confirmed by viability counts on YPD and BHI plates
(100 µL of diluted cells). Crude essential oil and reference standards were serial diluted (two-fold) and
added to each well. A sterilization control containing medium only and growth control containing
cell, DMSO (10 µL), or saline (10 µL), and Tween 80 were included as negative and positive controls,
respectively. Depending on the microorganism the microtiter plates were then incubated at 30 ◦C for
24 or 48 h. Microorganism growth was determined by reading the absorbance at 530 nm in a plate
reader Logen MT-960 (Tecan, Männedorf, Switzerland) and the minimum inhibitory concentration
was considered the lowest concentration at which at least 80% of growth was inhibited. All tests were
performed in triplicate.
3. Results and Discussion
3.1. Chemical Composition of Essential Oil from L. alba
The yield of the essential oil extracted from L. alba was 0.21% based on the weight of the fresh
leaves used in the distillation procedure. Analysis of the crude oil by gas chromatography with flame
ionization detector (GC-FID) and by gas chromatography coupled to low resolution electronic impact
mass spectrometry (GC-LREIMS), followed by calculation of Kovats indices, and comparison with the
literature data [27] allowed the identification of 39 compounds corresponding to 99.45% (Table 2) of
the crude essential oil.
Among the identified compounds, approximately 67% corresponds to monoterpenes and 19% to
sesquiterpenes. The main characterized components were the isomeric monoterpenes nerol/geraniol
(27.09%) and citral (21.87%), as well as 6-methyl-5-heptene-2-one (11.98%) and E-caryophyllene (9.25%),
as showed in Figure 1. These compounds were previously found as minor metabolites in the essential
oil from leaves of L. alba [29], suggesting the new chemotype nerol/geraniol and citral to the studied oil.
To confirm the identification of these main monoterpenes, the 13C NMR spectrum of crude oil
was recorded and exhibited peaks assigned to carbonyl groups of aldehydes (C-1) at δ 191.5 and 190.9
of geranial and neral, respectively. The peaks at δ 127.4/128.6 and δ 122.5/122.2 were assigned to
double bonds (C-2 and C-6), whereas those at δ 164.2/164.2 and δ 132.9/133.7 were attributed to C-3
and C-7 of geranial and neral, respectively. The secondary carbons C-4 and C-5 were represented by
signals δ 40.6/25.7 and 32.6/27.0. The signals of carbons C-8 (δ 17.7) and C-9 (δ 25.6) displayed the
same chemical shift for neral and geranial, but the peaks observed to C-10 were observed at δ 25.1 to
neral and δ 17.6 to geranial, according to literature data [30,31]. Finally, analysis of 1H NMR spectrum
Medicines 2016, 3, 22 5 of 9
indicated a ratio of 5:3 of geranial:neral based in the integration of the doublets at δ 9.99 (J = 9.0 Hz)
and 9.89 (J = 9.0 Hz), assigned to aldehyde hydrogens (H-1).
Table 2. Chemical composition of the essential oil obtained from leaves of L. alba.
Compound IK Relative Amount
α-pinene 939 0.15
Sabinene 976 0.41
6-methy-5-hepten-2-one 985 11.98
α-phelandrene 1005 3.25
α-terpinene 1018 0.23
β-phelandrene 1031 1.67
Z-β-ocimene 1040 0.18
E-β-ocimene 1050 2.70
γ-terpinene 1062 0.03
cis-sabinene hydrate 1068 0.04
Terpinolene 1088 0.02
Linalol 1098 2.14
cis-oxide rose 1111 0.80
Dihydrolinalol 1134 0.14
Citronelal 1153 0.45
Borneol 1165 0.33
α-terpineol 1189 1.15
Citronelol 1228 4.43
nerol/geraniol 1252 27.09
citral (neral/geranial) 1267 21.87
geranyl formate 1300 1.48
Longicyclene 1373 0.11
Longifolene 1402 1.65
α-cedrene 1409 0.62
E-caryophyllene 1418 9.25
cis-thujopsene 1429 0.12
α-humulene 1454 0.82
allo-aromadendrene 1461 0.25
α-acoradiene 1463 0.04
Chamigrene 1475 0.04
germacrene-D 1480 1.67
Ar-curcumene 1483 0.38
α-zingiberene 1495 0.97
germacrene-A 1503 0.98
β-bisabolene 1509 0.20
Z-γ-bisabolene 1515 0.18
epi-longipinanol 1561 0.03
Longipinanol 1566 1.53
(6R,7R)-bisabolone 1737 0.07
Monoterpenes 67.08
Sesquiterpenes 18.91
Other compounds 13.46
Total 99.45Medicines 2016, 3, 22 6 of 9 
 
 
   
 
Figure 1. Structures of main compounds identified in essential oil from L. alba: nerol (1), geraniol (2), 
neral (3), geranial (4), 6-methy-5-hepten-2-one, (5) and E-caryophyllene (6). 
3.2. Cytotoxic Activity 
The essential oil from leaves of L. alba was evaluated for its cytotoxic activity in vitro against the 
lines B16F10Nex2 and A549 with IC50 of 45.8 µg/mL and 63.9 µg/mL, respectively, and IC50 higher 
than 100 µg/mL to the MCF-7 cell line. Comparatively, positive control cisplatin displayed IC50 of 52.8 
µg/mL (B16F10Nex2), whereas paclitaxel showed IC50 of 84.3 µg/mL (A549) and 171.5 µg/mL (MCF), 
as showed in Table 3. Based in the obtained results, the essential oil from L. alba could be considered 
as a source of antitumor compounds, since it showed lower IC50 values in comparison to standard 
drugs in the tested cells. Additionally, the essential oil from L. alba was non-toxic to non-tumorigenic 
in HUVEC, in opposition to the cisplatin positive control, which displayed an IC50 value of 42.6 
μg/mL. 
Table 3. IC50 (µg/mL) values to the essential oil from leaves of L. alba and to positive control (cisplatin 
and paclitaxel) against cell lines. 
Cell Line 
IC50 (µg/mL)
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B16F10Nex2 45.82 ± 4.16 52.8 ± 4.50 - 
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MCF-7 >100 - 171.5 ± 16.39 
HUVEC >100 42.6 ± 2.25 - 
In a previous study concerning the cytotoxic activity of essential oils from L. alba against cell 
lines CT26WT (murine colon carcinoma), A549 (human lung adenocarcinoma), MDA-MB-231 
(human breast adenocarcinoma), CACO 2 (human colon carcinoma), and CHO (normal hamster 
ovary cells) no activity was observed to chemotype geraniol, whereas chemotype carvone inhibited 
A549 cells with IC50 of 47.80 µg/mL [32,33]. Otherwise, citral and carvone chemotypes of L. alba 
displayed dose-dependent cytotoxicity effect against HeLa (human cervical carcinoma) cells [34]. 
Regarding the major component citral, this compound exhibited antitumor activity. The effect of 
citral combined with retinoic acid showed inhibition of proliferation of A549 (lung carcinoma 
epithelial) in a dose dependent manner [35]. Additionally, antitumor properties was detected to 
micelle formulation of citral [36], whereas cytotoxicity against colon adenocarcinoma (HCT) and lung 
adenocarcinoma was described for citral, administrated as a mixture of monoterpenes neral + 
geranial and in a combination with lysine [37]. Geraniol, another main compound found in the 
studied essential oil from L. alba, was described as an inhibitor of prostate cancer growth by targeting 
cell cycle and apoptosis pathways [38].  
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Figure 1. Structures of main compounds identified in essential oil from L. alba: nerol (1), geraniol (2),
neral (3), geranial (4), 6-methy-5-hepten-2-one, (5) and E-caryophyllene (6).
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3.2. Cytotoxic Activity
The essential oil from leaves of L. alba was evaluated for its cytotoxic activity in vitro against
the lines B16F10Nex2 and A549 with IC50 of 45.8 µg/mL and 63.9 µg/mL, respectively, and IC50
higher than 100 µg/mL to the MCF-7 cell line. Comparatively, positive control cisplatin displayed IC50
of 52.8 µg/mL (B16F10Nex2), whereas paclitaxel showed IC50 of 84.3 µg/mL (A549) and 171.5 µg/mL
(MCF), as showed in Table 3. Based in the obtained results, the essential oil from L. alba could be
considered as a source of antitumor compounds, since it showed lower IC50 values in comparison
to standard drugs in the tested cells. Additionally, the essential oil from L. alba was non-toxic to
non-tumorigenic in HUVEC, in opposition to the cisplatin positive control, which displayed an IC50
value of 42.6 µg/mL.
Table 3. IC50 (µg/mL) values to the essential oil from leaves of L. alba and to positive control (cisplatin
and paclitaxel) against cell lines.
Cell Line
IC50 (µg/mL)
Essential Oil Cisplatin Paclitaxel
B16F10Nex2 45.82 ± 4.16 52.8 ± 4.50 -
A549 63.98 ± 6.76 - 84.3 ± 6.83
MCF-7 >100 - 171.5 ± 16.39
HUVEC >100 42.6 ± 2.25 -
In a previous study concerning the cytotoxic activity of essential oils from L. alba against cell
lines CT26WT (murine colon carcinoma), A549 (human lung adenocarcinoma), MDA-MB-231 (human
breast adenocarcinoma), CACO 2 (human colon carcinoma), and CHO (normal hamster ovary cells)
no activity was observed to chemotype geraniol, whereas chemotype carvone inhibited A549 cells
with IC50 of 47.80 µg/mL [32,33]. Otherwise, citral and carvone chemotypes of L. alba displayed
dose-dependent cytotoxicity effect against HeLa (human cervical carcinoma) cells [34]. Regarding the
major component citral, this compound exhibited antitumor activity. The effect of citral combined
with retinoic acid showed inhibition of proliferation of A549 (lung carcinoma epithelial) in a dose
dependent manner [35]. Additionally, antitumor properties was detected to micelle formulation
of citral [36], whereas cytotoxicity against colon adenocarcinoma (HCT) and lung adenocarcinoma
was described for citral, administrated as a mixture of monoterpenes neral + geranial and in a
combination with lysine [37]. Geraniol, another main compound found in the studied essential oil from
L. alba, was described as an inhibitor of prostate cancer growth by targeting cell cycle and apoptosis
pathways [38].
3.3. Antimicrobial Activity
Initially, disk diffusion assays were conducted with the yeasts and bacterial strains listed in
Table 1 in order to screen for antimicrobial activity. Four bacterial strains (two Gram-negative and
two Gram-positive) were sensitive to the essential oil from L. alba. In sequence, the species listed in
Table 4 were tested to determine the MICs. The results showed that yeasts are considerably more
sensitive to essential oil from L. alba than bacterial strains. At 4 mg/mL only E. coli showed a growth
inhibition over 80%; all other strains showed an MIC of 4.0 mg/mL with growth inhibitions below
70%. Conversely, all yeast strains tested were sensitive to the essential oil from L. alba and the MICs
calculated for them was two- to four-fold lower than those found for bacterial strains. C. dubliniensis
was the microbial strain most sensitive to essential oil from L. alba (0.5 mg/mL). All yeast strains tested
showed, at least, 90% of growth inhibition.
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Table 4. Minimum inhibitory concentrations (MIC) for essential oil from L. alba. Concentrations
are given in mg/mL. Numbers in parentheses denote the percentage of growth inhibition and its
standard deviation.
Species Essential Oil Positive Control
E. coli 4.0 (98% ± 1%) 0.01 a
S. marcescens 4.0 (42% ± 3%) 0.01 a
E. faecalis 4.0 (64% ± 2%) 0.02 a
S. epidermidis 4.0 (56% ± 2%) 0.04 a
C. albicans 2.0 (99% ± 2%) 0.025 b
C. dubliniensis 0.5 (93% ± 2%) 0.006 b
C. tropicalis 2.0 (99% ± 1%) 0.05 b
C. glabrata 2.0 (99% ± 1%) 0.05 b
C. parapsilosis 2.0 (99% ± 1%) 0.006 b
C. krusei 2.0 (99% ± 1%) 0.05 b
C. grubii (A) 1.0 (99% ± 2%) 0.013 b
C. gattii (B) 2.0 (97% ± 2%) 0.025 b
C. gattii (C) 2.0 (98% ± 1%) 0.006 b
C. neoformans (D) 1.0 (98% ± 2%) 0.006 b
S. cerevisiae 2.0 (99% ± 1%) 0.013 b
a chloramphenicol; b fluconazole.
There are many reports in the literature about the antimicrobial effects of essential oils from L. alba.
In our investigation the activity of this oil on bacterial growth was modest, suggesting that the tested
crude oil does not play an important role as an antibacterial. However, future studies with purified
fractions from this oil could uncover more significant biological activities against bacteria, as shown
before by Klein et al. [39]. Essential oils from L. alba have been extensively reported as antifungal,
especially against phyto [40–43] and human pathogens [43]. In summary, these results hold a promise
of possible applications for L. alba essential oil as an antifungal in medicine, as well as in agriculture.
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